1. Home
  2. MLP vs CLLS Comparison

MLP vs CLLS Comparison

Compare MLP & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLP

Maui Land & Pineapple Company Inc.

HOLD

Current Price

$16.01

Market Cap

323.5M

Sector

Finance

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.28

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLP
CLLS
Founded
1909
1999
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.5M
384.3M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
MLP
CLLS
Price
$16.01
$4.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
16.0K
28.9K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,457,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.62
P/E Ratio
N/A
N/A
Revenue Growth
68.24
N/A
52 Week Low
$13.84
$1.33
52 Week High
$20.34
$5.48

Technical Indicators

Market Signals
Indicator
MLP
CLLS
Relative Strength Index (RSI) 48.16 69.97
Support Level $15.57 $3.39
Resistance Level $16.26 $4.46
Average True Range (ATR) 0.44 0.20
MACD 0.08 0.10
Stochastic Oscillator 49.13 85.90

Price Performance

Historical Comparison
MLP
CLLS

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: